Evidence map›Paper›PMID 29275459›Full record

ArticleJournal of cell communication and signaling2018

Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin.

Salma Abdi Mahmoud, Mohammed Mohammed Ibrahim, Ahmed Hago Musa, Yuhong Huang, Jun Zhang, Jingwen Wang, Yuanyi Wei, Li Wang, Shunting Zhou, Boyi Xin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cell communication and signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Salma Abdi MahmoudDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Mohammed Mohammed IbrahimDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Ahmed Hago MusaDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Yuhong HuangDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Jun ZhangDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Jingwen WangDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Yuanyi WeiDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Li WangDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Shunting ZhouDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Boyi XinDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Wei XuanDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China.
Jianwu TangDepartment of Pathology and Pathophysiology, Key laboratory for Tumor Metastasis and Intervention of Liaoning Province, Dalian Medical University, 9 west Lvshun Southern road, Dalian, Liaoning, 116044, China. jianwutang@163.com.
Dalian Medical University · CN

Funding

Financial Department of Liaoning Province 20121203National Natural Science Foundation of China 81071725 and No. 30772468
6 · The paper itself

Abstract

Our previous study (Oncotarget 2016; 7:46) demonstrated that the over-expression of sulfatase-1 in murine hepatocarcinoma Hca-F cell line (a murine HCC cell with lymph node metastatic [LNM] rate of >75%) downregulates mesothelin and leads to reduction in lymphatic metastasis, both in vitro and in vivo. In current work, we investigated the effects of Sulf-1 knockdown on mesothelin (Msln) and it's effects on the in vitro cell proliferation, migration, invasion, and in vivo tumor growth and LNM rate for Hca-P cells (a murine HCC cell with LNM rate of <25%). Western blotting and qRT-PCR assay indicated that both in vitro and in vivo Sulf-1 was down-regulated by 75% and 68% and led to up regulation of Msln by 55% in shRNA-transfected-Sulf-1-Hca-P cells compared with Hca-P and nonspecific sequence control plasmid transfected Hca-P cell (shRNA-Nc-Hca-P). The in vitro proliferation, migration and invasion potentials were significantly enhanced following Sulf-1 stable down-regulation. In addition, Sulf-1 knock-down significantly promoted tumor growth and increased LNM rates of shRNA-Sulf-1-Hca-P-transplanted mice by 78.6% (11 out of 14 lymph nodes were positive of cancer). Consistent with our previous work, we confirmed that Sulf-1 plays an important role in hepatocarcinoma cell proliferation, migration, invasion and metastasis. The interaction between Sulf-1 and Msln is a potential therapeutic target in the development of liver cancer therapy.

Indexed as

Hepatocellular carcinomaLymph node metastasisMesothelinMigration and invasionSulfatase-1

Identifiers

PMID29275459
PMCPMC6039345
OpenAlexW2777867499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.